American Federation for Aging Research

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">American Federation for Aging Research</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>New York, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Non-profit Research Foundation</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1969</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.afar.org/" target="_blank">https://www.afar.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Aging Biology, Alzheimer's Disease, Parkinson's Disease, Age-Related Diseases</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Glenn Foundation for Medical Research</td>
</tr>
</table>

American Federation for Aging Research

Overview

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">American Federation for Aging Research</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>New York, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Non-profit Research Foundation</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1969</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.afar.org/" target="_blank">https://www.afar.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Aging Biology, Alzheimer's Disease, Parkinson's Disease, Age-Related Diseases</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Glenn Foundation for Medical Research</td>
</tr>
</table>

American Federation for Aging Research

Overview

The American Federation for Aging Research (AFAR) is a leading non-profit organization dedicated to supporting cutting-edge research on the biology of aging and age-related diseases. Founded in 1969, AFAR has become one of the premier funders of aging research in the United States, providing grants and fellowships to emerging and established scientists studying the mechanisms of aging and its relationship to neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease)[@afar].

AFAR's mission is to advance understanding of the biological processes that underlie aging and age-related diseases, with the ultimate goal of developing interventions that can extend healthy lifespan and prevent or treat age-related neurodegenerative conditions. The organization achieves this through its grant programs, public education initiatives, and strategic partnerships with other research foundations["@afara"].

History and Mission

Founding and Early History

AFAR was founded in 1969 by a group of physicians and scientists who recognized the growing importance of aging research as life expectancy increased in the United States. From its inception, AFAR has focused on supporting innovative research that explores the fundamental biology of aging and its implications for human health[@afar].

The organization was established during a period of increasing awareness about the challenges posed by an aging population. As medical advances led to longer lifespans, the incidence of age-related diseases including Alzheimer's and Parkinson's also rose, creating an urgent need for research into the underlying mechanisms of aging itself[@afara].

Evolution and Growth

Over the past five decades, AFAR has evolved from a small professional organization into a major force in aging research. The federation has supported thousands of researchers and has played a pivotal role in establishing aging research as a legitimate and important field of scientific inquiry. AFAR has been instrumental in fostering the careers of many leading researchers in the field of gerontology and neurodegenerative disease research[@afarb].

Funding Programs

AFAR Grants Program

AFAR administers several major grant programs that support research on the biology of aging:

AFAR Research Grants provide funding to established investigators pursuing innovative research projects focused on the basic biology of aging. These grants are designed to support projects that may be too innovative or high-risk for traditional funding mechanisms but have the potential to significantly advance the field[@afar].

AFAR Junior Faculty Awards support early-career investigators who are establishing independent research programs in aging research. These awards are particularly important for researchers seeking to make the transition from postdoctoral training to independent faculty positions[@afara].

AFAR postdoctoral Fellowships provide support for promising young researchers who are training in laboratories focused on aging-related research. These fellowships are designed to cultivate the next generation of leaders in the field[@afarb].

Glenn Foundation for Medical Research Partnership

AFAR maintains a significant partnership with the Glenn Foundation for Medical Research (GFMR), which has enabled the organization to expand its funding portfolio significantly. This partnership supports the Glenn Foundation's mission to advance understanding of the biological mechanisms of aging through supporting high-quality research programs[@glenn].

The AFAR-GFMR partnership has funded numerous studies on the cellular and molecular mechanisms of aging, including research on:

• Cellular senescence and its role in age-related neurodegeneration
• Mitochondrial dysfunction in aging [neurons](/entities/neurons)
• Protein homeostasis and aggregation in aging brains
• Neuroinflammation as a driver of age-related cognitive decline

Focus on Neurodegenerative Diseases

Alzheimer's Disease Research

AFAR has been a significant supporter of Alzheimer's Disease research, funding studies that explore the intersection of aging biology and Alzheimer's pathogenesis. Research funded by AFAR has contributed to understanding how aging-related cellular processes may contribute to [amyloid-beta](/proteins/amyloid-beta) accumulation, [tau](/proteins/tau) phosphorylation, and neurodegeneration in Alzheimer's disease[@afar][@afara].

Key areas of AFAR-funded Alzheimer's research include:

• The role of cellular senescence in Alzheimer's progression
• Mitochondrial dysfunction and energy metabolism in Alzheimer's brains
• Neuroinflammation as both a cause and consequence of Alzheimer's pathology
• Genetic and environmental factors that modify Alzheimer's risk

Parkinson's Disease Research

Similarly, AFAR supports Parkinson's Disease research that examines how aging-related mechanisms contribute to dopaminergic neuron loss and Parkinson's pathogenesis. The organization has funded research on:

• [Alpha-synuclein](/proteins/alpha-synuclein) aggregation and propagation
• Mitochondrial dysfunction in dopaminergic neurons
• Neuroinflammation in Parkinson's disease
• [LRRK2](/entities/lrrk2) and other genetic risk factors[@afarb]

Recent Awards and Highlights

AFAR recognizes outstanding contributions to aging research through its awards programs:

The Irving S. Zuckerman Award is AFAR's highest honor, awarded to researchers who have made exceptional contributions to the field of aging biology[@afara].

AFAR Grantee Highlights showcase recent discoveries by AFAR-funded researchers, including advances in understanding:

• Senolytic drugs that can selectively eliminate senescent cells
• Interventions that improve mitochondrial function in aging neurons
• Novel biomarkers for early detection of age-related cognitive decline[@afarb]

Strategic Priorities

AFAR's current strategic priorities include:

AFAR-Funded Research Breakthroughs

Hallmarks of Aging Framework

AFAR has been instrumental in supporting research that has defined the hallmarks of aging framework, originally published in Cell in 2013[@kennedy2014] and expanded in 2023[@lopezotin2023]. This conceptual framework identifies the fundamental cellular and molecular processes that contribute to aging and age-related diseases:

| Hallmark | Relevance to Neurodegeneration |
|----------|-------------------------------|
| Genomic instability | Accumulation of DNA damage in neurons |
| Telomere attrition | Neural stem cell exhaustion |
| Epigenetic alterations | Dysregulated gene expression in aging brains |
| Loss of proteostasis | Protein aggregation in AD and PD |
| Deregulated nutrient sensing | Metabolic dysfunction in neurodegeneration |
| Mitochondrial dysfunction | Energy failure in dopaminergic neurons |
| Cellular senescence | Senescent glia contribute to neuroinflammation |
| Stem cell exhaustion | Impaired neural regeneration |
| Altered intercellular communication | Dysregulated neuroimmune signaling |

Senolytics and Senostatics

AFAR has supported pioneering research on senolytics - drugs that selectively eliminate senescent cells - which has emerged as a promising therapeutic approach for age-related neurodegenerative diseases[@kirkland2023]:

• Dasatinib + Quercetin: First senolytic combination shown to reduce senescent cells in vivo
• Fisetin: Natural senolytic flavonoid with promising pre-clinical data
• Navitoclax: Bcl-2 family inhibitor with senolytic activity

• Reduce neuroinflammation in mouse models of AD and PD
• Improve cognitive function in aged animals
• Protect dopaminergic neurons from degeneration

Mitochondrial Interventions

Research funded by AFAR has advanced understanding of mitochondrial dysfunction in aging neurons and explored interventions:

• NAD+ supplementation: Precursor molecules (NMN, NR) restore mitochondrial function
• Mitochondrial quality control: Mitophagy enhancers promote damaged mitochondria clearance
• Metabolic modulators: Small molecules that improve neuronal energy metabolism

Neuroimmunology Advances

AFAR has supported research on the critical role of neuroinflammation in neurodegeneration:

• Microglia dysfunction: Age-related changes in microglial activation states
• Systemic inflammation: How peripheral immune signals affect brain function
• Inflammaging: Chronic low-grade inflammation as a driver of cognitive decline

Grant Programs in Detail

AFAR Research Grants

AFAR Research Grants provide $100,000-$150,000 over 1-2 years for established investigators. Priority areas include:

• Basic biology of aging mechanisms relevant to neurodegeneration
• Translation of aging research to clinical applications
• Novel therapeutic approaches for age-related diseases
• Biomarker development for aging and neurodegeneration

AFAR Junior Faculty Awards

The AFAR Junior Faculty Award in Aging provides $80,000 over two years for early-career investigators. Recent recipients have conducted research on:

• Epigenetic regulation of brain aging
• Proteostasis mechanisms in neuronal health
• Neuroinflammation modulation strategies

Glenn Foundation for Medical Research Awards

Through the partnership with GFMR, AFAR distributes:

• Glenn Foundation Fellowships: Postdoctoral training support
• Glenn Foundation Senior Investigator Awards: Established researchers
• Glenn Foundation Bridge Grants: COVID-19 impacted researchers

Paul Beeson Career Development Awards

AFAR administers the prestigious Paul Beeson Aging Research Fellowship, a $500,000 award over three years for early-career physician-scientists focused on aging-related research.

Impact and Outcomes

Research Productivity

| Metric | Value |
|--------|-------|
| Active grantees annually | 150+ |
| Cumulative grants awarded | 2,500+ |
| Papers published by grantees | 10,000+ |
| Grantees in NIH-funded positions | 75%+ |

Career Development Impact

AFAR has played a critical role in developing the next generation of aging researchers:

• First independent grant: Many AFAR alumni receive their first R01 as a result of AFAR support
• Leadership positions: AFAR grantees lead major research centers and departments
• Society leadership: AFAR alumni hold leadership positions in key professional organizations

Scientific Advances

AFAR-funded research has contributed to major advances including:

Collaborations and Partnerships

NIH Partnerships

AFAR works closely with the National Institute on Aging (NIA) and other NIH institutes:

• NIA-funded centers: AFAR investigators lead many NIA-funded Alzheimer's Disease Research Centers
• NIH grant programs: AFAR provides co-funding for targeted initiatives
• Consortium participation: AFAR researchers contribute to major collaborative efforts

International Collaborations

AFAR supports international research through:

• Global partnerships: Collaborations with aging research organizations worldwide
• International conferences: Co-sponsorship of major aging research meetings
• Visiting researcher programs: Support for international research exchanges

Industry Partnerships

AFAR facilitates translation through industry collaborations:

• Pharmaceutical partnerships: Working with companies on clinical development
• Biotech support: Funding early-stage companies developing anti-aging therapies
• Clinical trial networks: Connecting grantees with industry partners

Future Directions

Emerging Research Priorities

AFAR's strategic plan for 2025-2030 focuses on:

Expansion Initiatives

AFAR is expanding its programs in several areas:

• Increasing diversity: Supporting underrepresented researchers in aging research
• Global reach: Expanding international partnerships and grant programs
• Clinical translation: Increasing support for early-stage clinical research
• Data sharing: Promoting open science and data availability

Technology Integration

AFAR is embracing new technologies:

• Artificial intelligence: Machine learning approaches to analyze aging data
• Single-cell analysis: Cell-type specific understanding of aging mechanisms
• Organ-on-chip: Microfluidic systems modeling aging in tissues

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References